Bosuvi 100mg Tablet
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Bosutinib (100mg)
Overview Bosuvi 100mg Tablet
Chronic myeloid leukemia (CML) is treated with Bosuvi 100mg tablets, an anticancer medication. This medication inhibits the proliferation and growth of cancerous cells, thus slowing disease progression. Dosage and duration of Bosuvi 100mg are determined by your physician; adhere strictly to their instructions. It can be taken with or without food, but consistent daily timing aids adherence. Abrupt cessation is to be avoided; continue treatment as prescribed. Commonly reported adverse effects include respiratory infections, nasopharyngitis, thrombocytopenia, leukopenia, anemia, headache, dyspnea, cough, elevated liver enzymes, diarrhea, vomiting, nausea, and abdominal pain. Report any discomfort to your doctor; mitigation strategies may be available. Seek immediate medical attention for severe headache, unilateral leg swelling, dyspnea, or visual/auditory disturbances. Prior to commencing Bosuvi 100mg, disclose all pre-existing conditions and concurrent medications to your physician. This medication is contraindicated in pregnant and breastfeeding individuals due to potential harm to the fetus.
Uses of Bosuvi 100mg Tablet
Chronic myeloid leukemia, a type of blood malignancy
Major Benefits of Bosuvi 100mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 100mg Bosuvi tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistency in timing is recommended.
Common Side effects of Bosuvi 100mg Tablet:
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Headache
- Cough
- Low blood platelets
- Anemia (low number of red blood cells)
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Respiratory tract infection
- Decreased white blood cell count (neutrophils)
- Breathlessness
- Increased liver enzymes
How to use Bosuvi 100mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Bosuvi 100mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Bosuvi 100mg Tablet works:
Bosuvi 100mg tablets function as a tyrosine kinase inhibitor, employed in cancer treatment. Its mechanism involves the targeted disruption of aberrant proteins driving cancerous proliferation and metastasis, thereby inhibiting or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bosuvi 100mg Tablet is of unknown safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Bosuvi 100mg tablets during pregnancy poses a confirmed risk to the unborn child, making it inadvisable. Nevertheless, in exceptionally serious circumstances where the potential advantages outweigh the hazards, a physician might exceptionally prescribe it. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Bosuvi 100mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability while using Bosuvi 100mg Tablet is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Bosuvi 100mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Bosuvi 100mg tablets; dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Bosuvi 100mg Tablet :
Omit any missed Bosuvi 100mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Bosuvi 100mg Tablet
| Label | Value |
|---|---|
| Chemical Type | 4-Aminoquinoline derivatives |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |

